Literature DB >> 25174588

CD97 inhibits cell migration in human fibrosarcoma cells by modulating TIMP-2/MT1- MMP/MMP-2 activity--role of GPS autoproteolysis and functional cooperation between the N- and C-terminal fragments.

Cheng-Chih Hsiao1, Wen-Chih Wang, Wan-Lin Kuo, Hsin-Yi Chen, Tse-Ching Chen, Jörg Hamann, Hsi-Hsien Lin.   

Abstract

CD97 is a tumor-associated adhesion-class G-protein-coupled receptor involved in modulating cell migration. Adhesion-class G-protein-coupled receptors are characterized by proteolytic cleavage at a G-protein-coupled receptor proteolysis site (GPS) into an N-terminal fragment (NTF) and a C-terminal fragment (CTF), which remain associated noncovalently. The molecular mechanism and the role of GPS proteolysis in CD97-modulated cell migration are not completely understood. We report here that CD97 expression in HT1080 fibrosarcoma cells enhanced tissue inhibitor of metalloproteinase-2 secretion, leading to reduced membrane type 1 matrix metalloproteinase and matrix metalloproteinase 2 activities. This, in turn, impaired cell migration and invasion in vitro and lung macrometastasis in vivo. CD97 expression also upregulated the expression of integrins, promoting cell adhesion. Importantly, these cellular functions absolutely required the presence of both the NTF and the CTF of CD97, confirming functional cooperation between the two receptor subunits. CD97 gene knockdown reversed these phenotypic changes. We conclude that GPS proteolysis and the functional interplay between the NTF and the CTF are indispensible for CD97 to inhibit HT1080 cell migration by suppressing matrix metalloproteinase activity.
© 2014 FEBS.

Entities:  

Keywords:  CD97; adhesion-class G-protein-coupled receptors (adhesion-GPCRs); cell migration; matrix metalloproteinases; metastasis

Mesh:

Substances:

Year:  2014        PMID: 25174588     DOI: 10.1111/febs.13027

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

Review 1.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

2.  Biochemical features of the adhesion G protein-coupled receptor CD97 related to its auto-proteolysis and HeLa cell attachment activities.

Authors:  Li-Yun Yang; Xiao-Fang Liu; Yang Yang; Lin-Lin Yang; Kai-Wen Liu; Yu-Bo Tang; Min Zhang; Min-Jia Tan; Shan-Mei Cheng; Ye-Chun Xu; Huai-Yu Yang; Zhi-Jie Liu; Gao-Jie Song; Wei Huang
Journal:  Acta Pharmacol Sin       Date:  2016-09-19       Impact factor: 6.150

Review 3.  Adhesion GPCRs in Tumorigenesis.

Authors:  Gabriela Aust; Dan Zhu; Erwin G Van Meir; Lei Xu
Journal:  Handb Exp Pharmacol       Date:  2016

Review 4.  Chemo- and mechanosensing by dendritic cells facilitate antigen surveillance in the spleen.

Authors:  Dan Liu; Lihui Duan; Jason G Cyster
Journal:  Immunol Rev       Date:  2022-03       Impact factor: 12.988

5.  CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells.

Authors:  Dan Liu; Lihui Duan; Lauren B Rodda; Erick Lu; Ying Xu; Jinping An; Longhui Qiu; Fengchun Liu; Mark R Looney; Zhiyong Yang; Christopher D C Allen; Zhongmei Li; Alexander Marson; Jason G Cyster
Journal:  Science       Date:  2022-02-11       Impact factor: 63.714

6.  Cancer Cell Mechanics: Adhesion G Protein-coupled Receptors in Action?

Authors:  Nicole Scholz
Journal:  Front Oncol       Date:  2018-03-13       Impact factor: 6.244

7.  Activation of Adhesion GPCR EMR2/ADGRE2 Induces Macrophage Differentiation and Inflammatory Responses via16/Akt/MAPK/NF-κB Signaling Pathways.

Authors:  Kuan-Yu I; Yi-Shu Huang; Ching-Hsun Hu; Wen-Yi Tseng; Chia-Hsin Cheng; Martin Stacey; Siamon Gordon; Gin-Wen Chang; Hsi-Hsien Lin
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

8.  The RGD motif is involved in CD97/ADGRE5-promoted cell adhesion and viability of HT1080 cells.

Authors:  Wen-Ye Tjong; Hsi-Hsien Lin
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.